© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, CASI Pharmaceuticals, Inc. (CASI) shows an Average True Range (ATR) of 0.1 and an Enterprise Value of 34.51M. Its average trading volume over the past 3 months is 112.85K, indicating liquidity. These fundamental metrics provide insight into CASI's underlying financial health and market activity.
CASI Pharmaceuticals, Inc. (CASI) technical indicators as of December 24, 2025: the SMA 20 is -17.1%, SMA 50 at -39.12%, and SMA 200 at -55.66%. The RSI 14 value is 25.91, suggesting its current momentum. These technical analysis signals help assess CASI's price trends and potential future movements.
CASI Pharmaceuticals, Inc. (CASI) stock performance overview as of December 24, 2025: The 52-week high is $3.47 (currently -78.29% below), and the 52-week low is $0.752 (currently -5.85% above). Over the past year, CASI's performance is -75.06%, compared to the S&P 500's 9.35% change.
According to market data, CASI Pharmaceuticals, Inc. (CASI) stock's recent performance metrics show that over the last month, CASI is -36.71%, with a Year-to-Date (YTD) performance of -73.39%. Over the past year, the stock has seen a -75.06% change. These figures summarize CASI's price movements across various periods, reflecting its historical returns.
According to current financial data, CASI stock's P/E (TTM) ratio is -0.25, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for CASI, including P/S (0.45), P/B (-0.43), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.